Towa Aims To Restore Japanese Trust In Generics Quality
‘Future Of Generics Companies Are Worrisome’
Japan’s Towa Pharmaceutical has published its fifth mid-term business plan, alongside financial results for the 12 months ended 31 March 2021.
Japan’s Towa Pharmaceutical has published its fifth mid-term business plan, alongside financial results for the 12 months ended 31 March 2021.